C07K 7/60
The cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
Official title: the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
C07K7/60 (The cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid) appears on 81 US grants and 103 published applications in this corpus.
Search patents in C07K- Granted patents
- 81
- Published applications
- 103
- Assignees
- 73
- Inventors
- 295
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 2 |
| 2008 | 4 | 2 |
| 2009 | 0 | 4 |
| 2010 | 2 | 3 |
| 2011 | 2 | 0 |
| 2012 | 2 | 3 |
| 2013 | 3 | 6 |
| 2014 | 7 | 5 |
| 2015 | 7 | 4 |
| 2016 | 1 | 8 |
| 2017 | 5 | 6 |
| 2018 | 2 | 5 |
| 2019 | 4 | 7 |
| 2020 | 5 | 4 |
| 2021 | 4 | 13 |
| 2022 | 4 | 5 |
| 2023 | 1 | 7 |
| 2024 | 3 | 3 |
| 2025 | 2 | 6 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cyclic peptide, cell scaffold material, cell separating material, and medium7 Jul 2026US 12,673,975 B2FUJIFILM Corporation
- Aryl substituted polymyxin derivatives20 Jan 2026US 12,528,837 B2Spero Therapeutics, Inc.
- Neurotensinergic agonists and methods of using same preventing or treating pain15 Jul 2025US 12,358,948 B2Socpra Sciences Sante Et Humaines S.E.C.
- Antifungal agents and uses thereof1 Jul 2025US 12,344,680 B2Napp Pharmaceutical Group Limited
- Polymyxin compounds and uses thereof19 Nov 2024US 12,146,004 B2Spero Therapeutics, Inc.
- Novel decapeptide and use thereof in antibacterial3 Sep 2026US 2026/0258085 A1Methycure Biotech Corp.
- Aryl substituted polymyxin derivatives16 Apr 2026US 2026/0103491 A1Spero Therapeutics, Inc.
- Macolacins and methods of use thereof13 Nov 2025US 2025/0346633 A1The Rockefeller University
- Antifungal agents and uses thereof18 Sep 2025US 2025/0289852 A1Napp Pharmaceutical Group Limited
- Lipidated polymyxin analogues11 Sep 2025US 2025/0282827 A1Auckland Uniservices Limited
Most cited
By later US patents
- Modular pressure support system184US 7,677,246 B2RIC Investments, LLC · 2010
- Cationic peptides and method for production55US 5,593,866 AThe University of British Columbia · 1997
- Conjugates for the prevention and treatment of sepsis37US 5,545,721 AOphidian Pharmaceuticals, Inc. · 1996
- Synthetic apelin mimetics for the treatment of heart failure36US 8,673,848 B2Novartis AG · 2014
- Compounds for use in antibacterial therapy28US 4,510,132 A1985